Background An individualized approach should be taken regarding the utilization of direct oral anticoagulants (DOAC) in frail and elderly populations with atrial fibrillation (AF). We hypothesized that among an elderly and frail population, where the risk of bleeding, both real and perceived, is very high, the proportion of patients with a dose regimen different from the formal indication would be particularly high due to potential underdosing. Methods We conducted a retrospective, observational study enrolling 327 patients with AF admitted to an Internal Medicine ward during a 1-year period and discharged with a DOAC prescription. We divided the population in 2 groups: patients prescribed a reduced dose without formal dose reduction criteria (underdosed, n=170) and the rest of the population (n=157), which included adequately dosed patients, both with normal dose (n=99) and correctly reduced dose (n=43) and overdosed patients (n=15). A 1-year follow-up was completed for all patients, assessing the following outcomes: all-cause mortality, stroke, systemic embolism and major bleeding. Results Patients were elderly (81.9±7.68) and frail (Katz index 3.35±2.36). Apixaban was the most commonly prescribed NOAC (38.8%), followed by rivaroxaban (36.4%) and dabigatran (24.8%). Among underdosed patients, apixaban was prescribed in 45.3% of patients, dabigatran in 29.4% and rivaroxaban 25.3%. Although only 18.3% of patients had clinical criteria for dose reduction, 65.4% were discharged with reduced dose and thus 52% were underdosed. Regarding 1-year outcomes, mortality (40.8% vs 25.5%, RR=1.6, p=0.003) and the combined stroke, systemic embolism and major bleeding event rate (10.1% vs 3.2%, RR=3.16, p=0.015) were higher for underdosed patients. Among underdosed patients, comparing with the rest of the population, the increased ischemic events rate (ischemic stroke and systemic embolism) did not reached statistical significance (3.7% vs. 1.9%, p=0.5), but it did for hemorrhagic events (major bleeding and hemorrhagic stroke) (6.1% vs 0.6%, p=0.01) On multivariate analysis, even after considering adjustment for age, Katz and CHAD2VAS2C scores, renal function and DOAC prescribed, DOAC underdosing was associated with a higher risk of both ischemic and hemorrhagic events (HR = 3.51, 95% CI 1.08–11.38). However, it lost its independent negative effect regarding mortality (HR 1.32, 95% CI 0.87–1.99). Survival and event rate in underdosed Conclusions There is a significant proportion of frail and elderly patients with AF that are underdosed. This subset has a significant survival disadvantage, eventually reflecting prescription bias. However, underdosed patients have also a higher event rate of both ischemic and hemorrhagic events, suggesting that underdosing fragile patients is not an effective strategy and that instead it may be hazardous.
ConclusionPsychotic symptoms can be the first sign and remain isolated for years. The importance of the awareness of these disorders resides in the possibility of detection in a precocious stage of the disease and rapid referral, which can lead to stabilization of the evolution or even reversion of some of the disorders symptoms. The detection in a psychiatric stage opens the possibility of early intervention in the course of the disease and correct referral for treatment, making it crucial to raise the awareness of clinical psychiatrists for signs that may suggest a NM disorder.
Conclusion:With the correct intervention, most of the cases remit, but a good part however remains beyond adult age. The persistence is associated with several risk factors, and psychiatric comorbidities in these cases tend to increase with the age. Estimates are that two thirds of the cases with a diagnosis of ADHD in the childhood maintain alterations of the disease, with or without criteria for the condition. Of those, most disguise the cognitive and behavioural gaps, but many maintaining the dysfunctionality of the disease, revealing itself a greater economic impact for families and society. It seems to exist benefit in the correct referral and follow up on the cases of ADHD when the condition remains in the adult age.Introduction: Attention Deficit and Hyperactivity Disorder (ADHD) is one of the more prevalent and studied neurodevelopmental disorders, coursing with dysfunction at three level of symptoms, hyperactivity, Impulsiveness and attention deficit. It has a heterogeneous and complex course that is based on Neurobiological theories. ADHD is a disease diagnosed usually in more precocious ages, like childhood, and with a follow up that goes beyond the reaching of adult age. Since adult age, there seems to be some difficulty in delineating the course and the impact of the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.